Cloning an artificial gene encoding angiostatic anginex: From designed peptide to functional recombinant protein - PubMed (original) (raw)

Cloning an artificial gene encoding angiostatic anginex: From designed peptide to functional recombinant protein

Ricardo J M G E Brandwijk et al. Biochem Biophys Res Commun. 2005.

Abstract

Anginex, a designed peptide 33-mer, is a potent angiogenesis inhibitor and anti-tumor agent in vivo. Anginex functions by inhibiting endothelial cell (EC) proliferation and migration leading to detachment and apoptosis of activated EC's. To better understand tumor endothelium targeting properties of anginex and enable its use in gene therapy, we constructed an artificial gene encoding the biologically exogenous peptide and produced the protein recombinantly in Pichia pastoris. Mass spectrometry shows recombinant anginex to be a dimer and circular dichroism shows the recombinant protein folds with beta-strand structure like the synthetic peptide. Moreover, like parent anginex, the recombinant protein is active at inhibiting EC growth and migration, as well as inhibiting angiogenesis in vivo in the chorioallantoic membrane of the chick embryo. This study demonstrated that it is possible to produce a functionally active protein version of a rationally designed peptide, using an artificial gene and the recombinant protein approach.

PubMed Disclaimer

Cited by

Galectin functions in cancer-associated inflammation and thrombosis.
Kruk L, Braun A, Cosset E, Gudermann T, Mammadova-Bach E. Kruk L, et al. Front Cardiovasc Med. 2023 Feb 17;10:1052959. doi: 10.3389/fcvm.2023.1052959. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36873388 Free PMC article. Review.
Identification of an H-Ras nanocluster disrupting peptide.
Steffen CL, Manoharan GB, Pavic K, Yeste-Vázquez A, Knuuttila M, Arora N, Zhou Y, Härmä H, Gaigneaux A, Grossmann TN, Abankwa DK. Steffen CL, et al. Commun Biol. 2024 Jul 9;7(1):837. doi: 10.1038/s42003-024-06523-9. Commun Biol. 2024. PMID: 38982284 Free PMC article.
Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy.
Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S, Verhofstad N, Nakabeppu Y, Baum LG, Bakkers J, Mayo KH, Poirier F, Griffioen AW. Thijssen VL, et al. Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):15975-80. doi: 10.1073/pnas.0603883103. Epub 2006 Oct 16. Proc Natl Acad Sci U S A. 2006. PMID: 17043243 Free PMC article.
Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology?
Reuwer AQ, Nowak-Sliwinska P, Mans LA, van der Loos CM, von der Thüsen JH, Twickler MT, Spek CA, Goffin V, Griffioen AW, Borensztajn KS. Reuwer AQ, et al. J Cell Mol Med. 2012 Sep;16(9):2035-48. doi: 10.1111/j.1582-4934.2011.01499.x. J Cell Mol Med. 2012. PMID: 22128761 Free PMC article.

Cloning an artificial gene encoding angiostatic anginex: From designed peptide to functional recombinant protein - PubMed (original) (raw)